{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Vigil Neuroscience, Inc."},"Symbol":{"label":"Symbol","value":"VIGL"},"Address":{"label":"Address","value":"1 BROADWAY, 7TH FLOOR,SUITE 07-300 SUITE 700, CAMBRIDGE, Massachusetts, 02142, United States"},"Phone":{"label":"Phone","value":"+1 857 254-4445"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families."},"CompanyUrl":{"label":"Company Url","value":"https://www.vigilneuro.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David Gray","title":"Chief Scientific Officer"},{"name":"Ivana Magovcevic-Liebisch","title":"President, Chief Executive Officer & Director"},{"name":"Kelly Neelon","title":"Vice President-CMC & Technical Operations"},{"name":"Kevin Durfee","title":"Vice President & Head-Information Technology"},{"name":"Petra Kaufmann","title":"Chief Medical Officer"},{"name":"Sharon Morani","title":"Director-Facilities & Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}